The enzyme aromatase converts androgens to estrogens. In the rare, autosomal recessive condition of aromatase deficiency, gene mutations result in decreased aromatase activity, leading to androgen excess and estrogen deficiency in males and females.
Aromatase deficiency is a cause of female pseudohermaphroditism (or disorder of sex development). Aromatase is an enzyme that converts androgen hormones to estradiol, an estrogen. Deficiency in this enzyme leads to excessive exposure of a fetus to androgens, resulting in virilization of the external genitalia. Virilization of the mother during pregnancy can also occur.
Other signs of aromatase deficiency are failure of puberty to progress, hypergonadotropic hypogonadism, polycystic ovaries, tall stature, and osteopenia.
Males with aromatase deficiency have normal external genitalia and puberty, but are still affected by osteoporosis and tall stature. Aromatase deficiency is caused by a mutation in the CYP19 gene.
Aromatase deficiency
Alerts and Notices
Important News & Links
Synopsis

Codes
ICD10CM:
E34.8 – Other specified endocrine disorders
SNOMEDCT:
427627006 – Maternal virilization due to placental aromatase deficiency
E34.8 – Other specified endocrine disorders
SNOMEDCT:
427627006 – Maternal virilization due to placental aromatase deficiency
Differential Diagnosis & Pitfalls
Differential diagnosis for 46,XX disorders of sexual development also includes congenital adrenal hyperplasia, gonadal dysgenesis (eg, Swyer syndrome), gestational hyperandrogenism, and SRY gene translocation.
For male patients, other causes of secondary osteoporosis should be considered.
For male patients, other causes of secondary osteoporosis should be considered.
Best Tests
Subscription Required
References
Subscription Required
Last Updated:01/11/2022